These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19432812)

  • 1. The rat as an animal model of Alzheimer's disease.
    Benedikz E; Kloskowska E; Winblad B
    J Cell Mol Med; 2009 Jun; 13(6):1034-42. PubMed ID: 19432812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A transgenic rat that develops Alzheimer's disease-like amyloid pathology, deficits in synaptic plasticity and cognitive impairment.
    Liu L; Orozco IJ; Planel E; Wen Y; Bretteville A; Krishnamurthy P; Wang L; Herman M; Figueroa H; Yu WH; Arancio O; Duff K
    Neurobiol Dis; 2008 Jul; 31(1):46-57. PubMed ID: 18504134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: transgenic models to test new chemicals and pharmaceuticals.
    Miller CC; Anderton BH
    Curr Opin Biotechnol; 1992 Dec; 3(6):683-6. PubMed ID: 1369125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of transgenic rats producing human beta-amyloid precursor protein as a model for Alzheimer's disease: transgene and endogenous APP genes are regulated tissue-specifically.
    Agca C; Fritz JJ; Walker LC; Levey AI; Chan AW; Lah JJ; Agca Y
    BMC Neurosci; 2008 Feb; 9():28. PubMed ID: 18302776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic mouse models of Alzheimer's disease.
    Sirinathsinghji DJ
    Biochem Soc Trans; 1998 Aug; 26(3):504-8. PubMed ID: 9765905
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein.
    Bates KA; Fonte J; Robertson TA; Martins RN; Harvey AR
    Neuroscience; 2002; 113(4):785-96. PubMed ID: 12182886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Animal models of Alzheimer's disease.
    Higgins LS
    Mol Med Today; 1999 Jun; 5(6):274-6. PubMed ID: 10475711
    [No Abstract]   [Full Text] [Related]  

  • 10. Motor impairment in Alzheimer's disease and transgenic Alzheimer's disease mouse models.
    Wirths O; Bayer TA
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():1-5. PubMed ID: 18184365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transgenic mouse models of Alzheimer's disease.
    Hock BJ; Lamb BT
    Trends Genet; 2001 Oct; 17(10):S7-12. PubMed ID: 11585670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of Alzheimer's Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor.
    Pu YZ; Liang L; Fu AL; Liu Y; Sun L; Li Q; Wu D; Sun MJ; Zhang YG; Zhao BQ
    Curr Alzheimer Res; 2017; 14(6):668-679. PubMed ID: 27978793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
    Lian H; Litvinchuk A; Chiang AC; Aithmitti N; Jankowsky JL; Zheng H
    J Neurosci; 2016 Jan; 36(2):577-89. PubMed ID: 26758846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuron-intrinsic origin of hyperexcitability during early pathogenesis of Alzheimer's disease: An Editorial Highlight for "Hippocampal hyperactivity in a rat model of Alzheimer's disease" on https://doi.org/10.1111/jnc.15323.
    Lee-Liu D; Gonzalez-Billault C
    J Neurochem; 2021 Aug; 158(3):586-588. PubMed ID: 33909918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic mouse models of Alzheimer's disease.
    Elder GA; Gama Sosa MA; De Gasperi R
    Mt Sinai J Med; 2010; 77(1):69-81. PubMed ID: 20101721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
    Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
    Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 18. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staining and Quantification of β-Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Christensen A; Pike CJ
    Methods Mol Biol; 2020; 2144():211-221. PubMed ID: 32410038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons.
    Harasta AE; Ittner LM
    Adv Neurobiol; 2017; 15():3-29. PubMed ID: 28674976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.